Section 2: Financial provisions.

For the application of 2° of III of Article L. 1121-16-1, the sponsor may, provided that he has a favourable opinion from the Committee for the Protection of Individuals, ask the Ministers responsible for health and social security to waive the reimbursement by the health insurance funds of experimental medicinal products or authorised auxiliaries or products which are the subject of the research, when they are not used under conditions…

I.-When the research mentioned in 1° and 2° of Article L. 1121-1 for commercial purposes is carried out in health establishments, or health centres, it is the subject of the agreement provided for in the second paragraph of IV of Article L. 1121-16-1, between the legal representative of the research site and the legal representative of the research sponsor. This agreement is referred to as a single agreement. It is…